BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22843926)

  • 1. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
    Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
    J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of PSK on recurrence of stage II/III gastric cancer].
    Tanaka H; Muguruma K; Kubo N; Amano R; Noda E; Yamada N; Yashiro M; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2258-60. PubMed ID: 21224540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
    Imaizumi M; Kondo T; Kamei H; Ichihashi H
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
    Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Ichihashi H; Kondo T; Nakazato H
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
    Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K
    Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
    Kondo T; Sakamoto J; Nakazato H
    Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.
    Iino Y; Yokoe T; Maemura M; Horiguchi J; Takei H; Ohwada S; Morishita Y
    Anticancer Res; 1995; 15(6B):2907-11. PubMed ID: 8669887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
    Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer.
    Oba K; Teramukai S; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
    Cancer Immunol Immunother; 2007 Jun; 56(6):905-11. PubMed ID: 17106715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
    Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
    Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of adjuvant immunochemotherapy in advanced gastric cancer].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2525-30. PubMed ID: 8279851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.
    Takahashi Y; Mai M; Nakazato H
    Anticancer Res; 2005; 25(2B):1377-84. PubMed ID: 15865094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
    Yoshinaga K; Saeki H; Oki E; Morita M; Ikeda T; Sugimachi K; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Kawanaka H; Mimori K; Watanabe M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):549-58. PubMed ID: 24693683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compound therapy including PSK for malignant head and neck cancer].
    Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.